The Euro Heart Survey program: what's in it for nurses?

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest (2009) 14.06

Universal definition of myocardial infarction. Circulation (2007) 11.69

Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med (2013) 11.14

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest (2010) 10.29

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Third universal definition of myocardial infarction. Circulation (2012) 8.47

Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (2002) 5.04

Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation (2003) 4.36

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation (2003) 4.31

Soluble CD40 ligand in acute coronary syndromes. N Engl J Med (2003) 4.06

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation (2007) 3.62

Acute myocardial infarction. Lancet (2003) 3.59

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J (2002) 3.36

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med (2002) 3.01

Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol (2010) 2.59

Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ (2013) 2.58

Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol (2005) 2.07

Sense of coherence and perceived physical health explain the better quality of life in adolescents with congenital heart disease. Eur J Cardiovasc Nurs (2013) 2.03

Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol (2007) 2.00

Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J (2005) 1.99

Congenital aortic stenosis in adults: rate of progression and predictors of clinical outcome. Int J Cardiol (2007) 1.97

Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. EuroIntervention (2009) 1.94

Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience. Eur J Oncol Nurs (2012) 1.92

Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial. Circulation (2012) 1.91

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med (2003) 1.81

Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol (2007) 1.81

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol (2003) 1.75

Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J (2007) 1.72

Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace (2008) 1.68

Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace (2012) 1.67

Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation (2003) 1.67

The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J (2005) 1.65

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. Eur Heart J (2009) 1.60

Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J (2011) 1.60

Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries. Europace (2010) 1.59

The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy. Eur Heart J (2005) 1.58

Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. Europace (2011) 1.57

Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J (2010) 1.57

Guidelines for cardiac management in noncardiac surgery are poorly implemented in clinical practice: results from a peripheral vascular survey in the Netherlands. Anesthesiology (2007) 1.57

Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. Eur Heart J (2008) 1.57

The effects of intra-aortic balloon pump support on macrocirculation and tissue microcirculation in patients with cardiogenic shock. Cardiology (2009) 1.57

Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med (2005) 1.56

Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls. Heart Rhythm (2012) 1.53

Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy. J Cardiovasc Electrophysiol (2011) 1.52

Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. Am J Med (2004) 1.51

Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant (2004) 1.50

Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA? Cardiovasc Drugs Ther (2008) 1.50

Prehospital versus hospital fibrinolytic therapy using automated versus cardiologist electrocardiographic diagnosis of myocardial infarction: abortion of myocardial infarction and unjustified fibrinolytic therapy. Am Heart J (2004) 1.48

The other side of the coin: perceived positive effects of illness in women following acute myocardial infarction. Eur J Cardiovasc Nurs (2007) 1.48

The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice. Eur Heart J (2004) 1.46

Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol (2007) 1.42

Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit. Pharmacogenomics (2010) 1.41

Management of cardiogenic shock: focus on tissue perfusion. Curr Probl Cardiol (2009) 1.40

Prognostic value of placental growth factor in patients with acute chest pain. JAMA (2004) 1.40

Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial. Arch Cardiovasc Dis (2009) 1.39

Clinical Effects and Implications of Cardiac Rehabilitation for Implantable Cardioverter Defibrillator Patients: A Mixed-Methods Approach Embedding Data From the Copenhagen Outpatient ProgrammE-Implantable Cardioverter Defibrillator Randomized Clinical Trial With Qualitative Data. J Cardiovasc Nurs (2015) 1.39

Long-term outcome and quality of life in adult patients after the Fontan operation. Am J Cardiol (2004) 1.33

Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation (2002) 1.30

Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res (2007) 1.30

Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study. Curr Control Trials Cardiovasc Med (2001) 1.30

The effectiveness of inpatient geriatric evaluation and management units: a systematic review and meta-analysis. J Am Geriatr Soc (2009) 1.22

The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med (2013) 1.20

Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization. Eur Heart J (2006) 1.18

What does it mean to live with a congenital heart disease? A qualitative study on the lived experiences of adult patients. Eur J Cardiovasc Nurs (2005) 1.17

Systematic adjudication of myocardial infarction end-points in an international clinical trial. Curr Control Trials Cardiovasc Med (2001) 1.17

Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers. J Am Coll Cardiol (2006) 1.16

Incidence, pathophysiology, and treatment of complications during dobutamine-atropine stress echocardiography. Circulation (2010) 1.16

Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure. Eur J Heart Fail (2009) 1.16

Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol (2006) 1.15

Third universal definition of myocardial infarction. Glob Heart (2012) 1.14

Changes in clinical profile, treatment, and mortality in patients hospitalised for acute myocardial infarction between 1985 and 2008. PLoS One (2011) 1.14

Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur Heart J (2006) 1.13

Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation (2002) 1.13

Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation (2003) 1.12

Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years. Int J Cardiol (2012) 1.12

Third universal definition of myocardial infarction. Nat Rev Cardiol (2012) 1.12

Sense of coherence as a resource for quality of life in patients with congenital heart disease: the benefits continue into adulthood. Eur J Cardiovasc Nurs (2013) 1.08

Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. Eur Heart J (2006) 1.05

ST2 and mortality in non-ST-segment elevation acute coronary syndrome. Am Heart J (2010) 1.03

Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. J Am Coll Cardiol (2006) 1.02

Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization. Am J Cardiol (2005) 1.01

Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. Eur Heart J (2013) 1.01

A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice. Eur Heart J (2013) 1.00

Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. J Am Coll Cardiol (2005) 1.00

Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J (2010) 1.00

Prediction of functional decline in older hospitalized patients: a comparative multicenter study of three screening tools. Aging Clin Exp Res (2012) 0.99

Real-time transthoracic three-dimensional echocardiographic assessment of left ventricular volume and ejection fraction in congenital heart disease. J Am Soc Echocardiogr (2006) 0.98

Measuring symptom experience of side-effects of immunosuppressive drugs: the Modified Transplant Symptom Occurrence and Distress Scale. Transpl Int (2008) 0.97

Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. Am Heart J (2003) 0.96

Prehospital stroke scales in a Belgian prehospital setting: a pilot study. Eur J Emerg Med (2010) 0.96

The electrical T-axis and the spatial QRS-T angle are independent predictors of long-term mortality in patients admitted with acute ischemic chest pain. Cardiology (2004) 0.96

Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure. Intensive Care Med (2009) 0.96

Beliefs and attitudes of intensive care nurses toward visits and open visiting policy. Intensive Care Med (2007) 0.96

Implementation of discharge management for geriatric patients at risk of readmission or institutionalization. Int J Qual Health Care (2006) 0.95